Skip to main content

ANNE One Platform

Continuous, Clinical‑Grade Wearable Monitoring for Patients

Problem

Traditional patient monitoring systems are cabled, bulky, and typically used only in the ICU setting. In the general medicine and surgery wards, vital signs may be checked only every 4 to 12 hours leading to blind spots where patients can deteriorate without early warning. 

Solution

The ANNE® One Platform is a wireless, wearable monitoring system that provides continuous, clinicalgrade data on key vital signs such as heart rate, respiratory rate, temperature, and pulse oxygenation. 

Developed by Sibel Health, the platform emerged from the pioneering work of McCormick Professor John Rogers’ lab, which specializes in biointegrated electronics. Rogers’ team created soft, skinlike sensors that conform to the body, enabling longterm monitoring without discomfort. 

ANNE® One integrates these sensors with a mobile device and cloud platform, allowing clinicians to remotely track multiple patients in real time. 

ANNE One enables continuous monitoring beyond the ICU, detecting patient deterioration earlier, supporting safer and faster discharges, and reducing nurse workload all at once.”

— Steve Xu, MD 
Assistant Professor, Feinberg School of Medicine
Chief Executive Officer, Sibel Health

Benefits

  • Continuous Monitoring: Provides uninterrupted, realtime data streams. 
  • Comfortable Design: Skinlike, wireless sensors eliminate wires and bulky equipment. 
  • Clinical‑Grade Accuracy: Validated against hospital monitors for accuracy and performance. 
  • Remote Care: Enables use cases for hospital at home and virtual wards. 
  • Versatility: Applicable for pediatric and adult monitoring in the home or hospital settings. 

Technology & Commercialization Status 

The ANNE® One Platform was spun out of research led by McCormick Professor John Rogers, a global leader in bioelectronics. His lab’s innovations in flexible, skinlike sensors laid the foundation for Sibel Health, the company commercializing ANNE® One. 

Sibel Health has since advanced the technology into an FDAcleared and CE-marked platform, deployed in hospitals, clinical trials, and home settings in high resource and low resource settings.  

Backed by partnerships with major health systems and global organizations, ANNE One is positioned as a scalable solution for nextgeneration digital health, bridging the gap between hospitalgrade monitoring and everyday care.

Northwestern Inventors 

John A. Rogers, PhD  
Louis Simpson and Kimberly Querrey Professor of Materials Science and Engineering  
McCormick School of Engineering  

Steve Xu, MD
Assistant Professor of Dermatology 
Feinberg School of Medicine 

Links 

Website: https://sibelhealth.com/   

Publications